Jackie Speier sold Xylem Inc (NYSE: XYL)
Jackie Speier (D-CA), a U.S. Representative, has disclosed 1 trade in Xylem Inc (XYL) since 2018, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Jackie Speier sold $1,001 - $15,000 of Xylem Inc (NYSE: XYL) on July 30, 2018. Since that trade, XYL is up +91.29% against the S&P 500 up +202.55%, an outperformance of -111.26%.
Data updated
Jackie Speier's XYL trades vs the price
XYL is up +91.29% since Jackie Speier sold on July 30, 2018, versus +202.55% for the S&P 500.
Performance since this trade
All Jackie Speier XYL trades
Jackie Speier & XYL trading FAQ
Is it legal for Jackie Speier to trade Xylem Inc (XYL) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Xylem Inc (XYL), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Jackie Speier sell XYL?
Jackie Speier disclosed a sale of $1,001 - $15,000 of Xylem Inc (XYL) on July 30, 2018, according to public STOCK Act filings.
How has XYL performed since Jackie Speier's trade?
Since Jackie Speier sold XYL on July 30, 2018, the stock is up +91.29%, versus +202.55% for the S&P 500 over the same period, an outperformance of -111.26%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional XYL trades?
Quantellect tracks every disclosed congressional trade in Xylem Inc (XYL) on the Xylem Inc congressional trading page, which aggregates filings across all members of Congress.
Jackie Speier's XYL tradesAll congressional filings for Xylem IncJackie Speier's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.